18 June 2013
Keywords: fisons, licenses, out, dopacard, keeping, its, corporate
Article | 15 February 1993
Fisons, in keeping with its corporate strategy of licensing-out compounds outside of its core specialist areas (primarily the respiratory and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.